Envision Healthcare Corporation (NYSE:EVHC) posted its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.04, Morningstar.com reports. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The company’s revenue was up 156.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.34 earnings per share. Envision Healthcare Corporation updated its Q3 guidance to $0.87-0.83 EPS and its FY17 guidance to $3.35-3.45 EPS.

Envision Healthcare Corporation (NYSE:EVHC) traded up 0.66% during midday trading on Friday, reaching $50.21. 1,433,281 shares of the company’s stock were exchanged. The stock’s 50-day moving average is $57.66 and its 200-day moving average is $60.47. Envision Healthcare Corporation has a 12-month low of $49.56 and a 12-month high of $74.75. The stock’s market capitalization is $5.88 billion.

A number of analysts have recently weighed in on the stock. Mizuho dropped their target price on shares of Envision Healthcare Corporation from $70.00 to $60.00 and set a “neutral” rating for the company in a report on Tuesday, May 30th. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a report on Friday, August 11th. Jefferies Group LLC set a $75.00 target price on shares of Envision Healthcare Corporation and gave the stock a “buy” rating in a report on Friday, April 21st. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 target price on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. Finally, BidaskClub lowered shares of Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $71.56.

WARNING: This story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/08/19/envision-healthcare-corporation-nyseevhc-posts-earnings-results-beats-expectations-by-0-10-eps-updated.html.

In other news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $60.00, for a total value of $90,000.00. Following the sale, the insider now owns 99,363 shares in the company, valued at $5,961,780. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 3.10% of the company’s stock.

Institutional investors have recently bought and sold shares of the stock. Quantitative Systematic Strategies LLC bought a new position in Envision Healthcare Corporation during the first quarter valued at about $373,000. Nisa Investment Advisors LLC increased its position in Envision Healthcare Corporation by 14,372.5% in the first quarter. Nisa Investment Advisors LLC now owns 28,945 shares of the company’s stock valued at $1,775,000 after buying an additional 28,745 shares during the last quarter. First United Bank Trust increased its position in Envision Healthcare Corporation by 31.2% in the first quarter. First United Bank Trust now owns 9,660 shares of the company’s stock valued at $592,000 after buying an additional 2,295 shares during the last quarter. National Investment Services Inc. WI bought a new position in Envision Healthcare Corporation during the first quarter valued at about $1,881,000. Finally, Atria Investments LLC increased its position in Envision Healthcare Corporation by 31.3% in the first quarter. Atria Investments LLC now owns 5,380 shares of the company’s stock valued at $330,000 after buying an additional 1,282 shares during the last quarter. 64.75% of the stock is currently owned by institutional investors and hedge funds.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Earnings History for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.